To include your compound in the COVID-19 Resource Center, submit it here.

Melior begins Phase IIb trial for Type II diabetes candidate MLR-1023

Melior Discovery Inc. (Exton, Pa.) spinout Melior Pharmaceuticals I Inc. began a Phase IIb trial of MLR-1023 to treat adults with Type

Read the full 220 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE